King Wealth Management Group’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ORGO
DM
GIM
PVI
APM
EMFAT
N
King Wealth Management Group's ORGO Position: Q1 2021 in Review
King Wealth Management Group sold out of Organogenesis Holdings (ORGO) in Q1 2021, closing a stake of 72,338 shares — an estimated $545K sold.
King Wealth Management Group first reported a position in ORGO in Q4 2020 and held it in 1 quarter. The position peaked at $545K in Q4 2020. 101 funds tracked by Wall St. Rank hold ORGO as of Q1 2021.
- King Wealth Management Group reported no remaining Organogenesis Holdings position as of Q1 2021 after selling out during the quarter.
- King Wealth Management Group sold 72,338 Organogenesis Holdings shares in Q1 2021, an estimated $545K.
- King Wealth Management Group first reported a position in Organogenesis Holdings in Q4 2020 and held it in 1 quarter.
- King Wealth Management Group's Organogenesis Holdings position peaked at $545K in Q4 2020.
- 101 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2021.
Based on King Wealth Management Group's 13F filing for Q1 2021, filed 14 May 2021.